EGFR-TKI plus bevacizumab as maintenance therapy for advanced lung adenocarcinoma: a retrospective study of 192 cases
Objective To compare the efficacy and safety of EGFR-TKI plus bevacizumab as maintenance therapy with EGFR-TKI alone for EGFR-mutated advanced lung adenocarcinoma. Methods Clinical data of 192 patients with advanced lung adenocarcinoma admitted in our hospital from 2013 to 2019 were collected and re...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Third Military Medical University
2021-04-01
|
| Series: | Di-san junyi daxue xuebao |
| Subjects: | |
| Online Access: | https://aammt.tmmu.edu.cn/Upload/rhtml/202011035.htm |